Isorhamnetin Regulates Programmed Death Ligand-1 Expression by Suppressing the EGFR–STAT3 Signaling Pathway in Canine Mammary Tumors.

MLA

Mei, Chen, et al. “Isorhamnetin Regulates Programmed Death Ligand-1 Expression by Suppressing the EGFR–STAT3 Signaling Pathway in Canine Mammary Tumors.” International Journal of Molecular Sciences, vol. 25, no. 1, Jan. 2024, p. 670. EBSCOhost, https://doi.org/10.3390/ijms25010670.

APA

Mei, C., Zhang, X., Zhi, Y., Liang, Z., Xu, H., Liu, Z., Liu, Y., Lyu, Y., & Wang, H. (2024). Isorhamnetin Regulates Programmed Death Ligand-1 Expression by Suppressing the EGFR–STAT3 Signaling Pathway in Canine Mammary Tumors. International Journal of Molecular Sciences, 25(1), 670. https://doi.org/10.3390/ijms25010670

Chicago

Mei, Chen, Xue Zhang, Yan Zhi, Zhixuan Liang, Haojun Xu, Zhenyi Liu, Ying Liu, Yanli Lyu, and Hongjun Wang. 2024. “Isorhamnetin Regulates Programmed Death Ligand-1 Expression by Suppressing the EGFR–STAT3 Signaling Pathway in Canine Mammary Tumors.” International Journal of Molecular Sciences 25 (1): 670. doi:10.3390/ijms25010670.